Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBD2 | Q9UBB5 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9043651 | 0.77 | GABRA5 (0.49) | KDM4EALDH1A1L3MBTL1ADORA1HPGD | |
| SCHEMBL9268169 | 0.75 | MBD2 (0.66) | MBD2KDM4EALDH1A1L3MBTL1ADORA1 | |
| SCHEMBL3590577 | 0.74 | MBD2 (0.47) | MBD2KDM4EALDH1A1L3MBTL1ADORA1 | |
| SCHEMBL25912261 | 0.73 | TSHR (0.36) | MAPK1ADORA3ADORA2ASMN1; SMN2PTPN2 | |
| SCHEMBL13394327 | 0.71 | MBD2 (0.64) | MBD2KDM4EALDH1A1L3MBTL1ADORA1 | |
| SCHEMBL635868 | 0.69 | ADORA1 (0.53) | KDM4EALDH1A1L3MBTL1ADORA1TP53 | |
| SCHEMBL26168118 | 0.69 | PTPN2 (0.49) | KDM4EALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL12799838 | 0.68 | DDB1 (0.41) | MBD2KDM4EALDH1A1L3MBTL1ADORA1 | |
| SCHEMBL20798562 | 0.68 | MBD2 (0.60) | MBD2KDM4EALDH1A1L3MBTL1ADORA1 | |
| SCHEMBL15730362 | 0.67 | ALDH1A1 (0.65) | KDM4EALDH1A1L3MBTL1ADORA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11716898-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-11716898-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORP (US) | 2020-09-17 | — | — | US | disclosed |
| US-10707427-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-08-17 | — | — | US | disclosed |
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-08-17 | — | — | US | disclosed |
| US-5623073-A | ANTIDIABETIC AGENT | ADIR ET COMPAGNIE (FR) | 1997-04-22 | — | — | US | disclosed |
| EP-0571253-A1 | Benzimidazole derivatives with antidiabetic and antiplatelet aggregation activity | ADIR ET COMPAGNIE (FR) | 1993-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | MBD2 70/4885KDM4E 2637/4885ALDH1A1 2423/4885 |
| US-11716898-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | MBD2 70/4885KDM4E 2637/4885ALDH1A1 2423/4885 |
| US-10707427-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | MBD2 63/4885KDM4E 3150/4885ALDH1A1 2262/4885 |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | MBD2 70/4885KDM4E 2637/4885ALDH1A1 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.